Achieving high-quality magnetic resonance enterography is critical for assessing Crohn’s disease activity
Open Access
- 30 April 2024
- journal article
- editorial
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 22 (2) , 117-118
Abstract
Thicker. Thus, achieving optimal bowel distension is essential for a precise evaluation of bowel wall thickness. This necessitates choosing the right oral contrast agent and fine-tuning the dosage and administration method. MRE involves ingesting a contrast agent orally, often resulting in insufficient distension of the proximal jejunum. Bohra et al. ' s findings echoed this issue. Although magnetic resonance enteroclysis can more reliably distend the intestines than MRE, its requirement for additional intubation can cause patient discomfort. Since Crohn' s disease more commonly affects the ileum than the jejunum, MRE remains the preferred method for most cases of Crohn' s disease. The irregular peristaltic movement of the small intestine can significantly degrade image quality, a concern for MRE given the lengthy image acquisition time. Antiperistaltic agents like glucagon and hyoscine butylbromide are used to mitigate peristalsis. The onset and duration of their effects vary based on the medication type and administration method. 6 While it typically takes more than 30 minutes to acquire a complete MRE, bowel movement begins to reappear after a mean period of 6.8 ± 5.3 minutes in hyoscine butylbromide intravenous (IV) group and after 18.3 ± 7.0 minutes in glucagon IV group. 7 This means that using a single medication may result in lower image quality towards the latter part of the image acquisition due to peristalsis. To overcome this, combination of 2 medications can be used, or the medication can be split and administered both at the start and midway through the examination. The type, amount, and method of administering oral conKeywords
This publication has 7 references indexed in Scilit:
- Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s diseaseIntestinal Research, 2024
- Crohn’s disease at radiological imaging: focus on techniques and intestinal tractIntestinal Research, 2021
- Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s DiseaseGastroenterology, 2019
- Non-perforating small bowel Crohn's disease assessed by MRI enterography: Derivation and histopathological validation of an MR-based activity indexEuropean Journal of Radiology, 2012
- Evaluation of the anti-peristaltic effect of glucagon and hyoscine on the small bowel: comparison of intravenous and intramuscular drug administrationEuropean Radiology, 2012
- Aperistaltic effect of hyoscine N-butylbromide versus glucagon on the small bowel assessed by magnetic resonance imagingEuropean Radiology, 2009
- Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s diseaseGut, 2009